We are here to help! If you can answer ‘yes’ to any of the following, we can provide educational information to your Urologist.
Are you:
Newly diagnosed with prostate cancer?
Currently on active surveillance?
If you are interested and would like us to reach out to your provider, please fill out their information below
You agree to be contacted with newsletters, marketing or promotional materials and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in any email we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Policy.
You’ll receive a personalized follow up call from a Myriad customer service representative, with the caller ID displaying Myriad Genetics Support Team – Prolaris Test.
Contact Information
The Prolaris Test is an advanced genetic test that combines tools like Gleason score and PSA with a personalized tumor score to determine how aggressive your prostate cancer is. The Prolaris Test helps you and your doctor decide the best treatment option based on your individual cancer.
Prostate cancer is personal and treatment should be too. The Prolaris Test is for any newly diagnosed man with prostate cancer and helps patients and providers answer pressing clinical questions like:
Get our free testing guide
65%
In two clinical utility studies, Prolaris Test results led to change in management in up to 65% of patients.1,2,3
2x
The Prolaris Test score is 2x more prognostic than PSA and Gleason score combined4
$0
Majority of patients face no out-of-pocket costs for the Prolaris Test.5
Watch how Richard and his doctor worked together to decide on the best treatment option for him based on his Prolaris Test results.
You may have inherited more than just your eye color from your parents
The MyRisk® Hereditary Cancer Test is a genetic test that identifies hereditary (germline) mutations to determine if you may have an inherited form of cancer. The MyRisk Test helps high-risk or metastatic prostate cancer patients qualify for new, personalized treatments – like targeted medications, clinical trials or if you have an elevated risk of developing a secondary cancer.
Request test kit
The Prolaris Test is a molecular diagnostic test that helps determine the aggressiveness of a prostate cancer tumor to determine if a patient may be appropriate to watch their cancer in favor of active surveillance or if they should pursue treatment.
The MyRisk Test screens for genetic variants linked to inherited cancers, helping identify individuals at increased risk based on their personal or family history. It can also assist in selecting patients for targeted therapies like PARP inhibitors and immunotherapy.
A somatic test that assesses 500+ genes, as well as key biomarkers like MSI, TMB and PD-L1, to determine if a patient’s tumor may be appropriate for novel therapies or clinical trials.
Contact our trusted advisors for personalized support.
Learn how genetic testing can provide better answers for the best prostate cancer treatment for you in our FREE Patient Testing Guide.
©2025 Myriad Genetics, Inc. Myriad Genetics, MyRisk, Precise Tumor, Prolaris and their respective logos, are registered trademarks of Myriad Genetics, Inc. and its subsidiaries in the United States and other jurisdictions.